Cybin Receives FDA Breakthrough Therapy Designation for its Novel Psychedelic Molecule CYB003 and Announces Positive Four-Month Durability Data in Major Depressive Disorder
TORONTO--(BUSINESS WIRE)--Mar 13, 2024--
Source: valdostadailytimes.com
Disability Around News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Disability Around. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Disability Around Today - Breaking & Trending Today
Researchers at Fermata to Study SAINT Neuromodulation for Treatment-Resistant Major Depression
/PRNewswire/ -- Fermata, an outpatient psychiatric center of excellence, today announced a new clinical trial to study the SAINT™ Neuromodulation System for...
Source: prnewswire.com
U.S. FDA Approves VRAYLAR® (cariprazine) as an Adjunctive Treatment for Major Depressive Disorder
- Approval marks fourth indication for VRAYLAR, backed by proven efficacy and well-established tolerability as an adjunctive treatment for major depressive...
Source: prnewswire.com